Template:AstraZeneca: Difference between revisions
From WikiMD's Wellness Encyclopedia
CSV import |
en>Allenkong11 mNo edit summary |
||
| Line 7: | Line 7: | ||
| group1 = Products | | group1 = Products | ||
| list1 = | | list1 = | ||
* [[Acalabrutinib]] | |||
* [[Anastrozole]] | * [[Anastrozole]] | ||
* [[Andexanet alfa]] | |||
* [[Anifrolumab]] | |||
* [[Asfotase alfa]] | |||
* [[Atenolol]] | * [[Atenolol]] | ||
* [[Benralizumab]] | |||
* [[Bicalutamide]] | * [[Bicalutamide]] | ||
* [[Brompheniramine]] | * [[Brompheniramine]] | ||
* [[Budesonide]] | * [[Budesonide]] | ||
* [[Budesonide/formoterol]] | |||
* [[Budesonide/glycopyrronium bromide/formoterol]] | |||
* [[Candesartan]] | |||
* [[Dapagliflozin]] | |||
* [[Disufenton sodium]] | * [[Disufenton sodium]] | ||
* [[Durvalumab]] | |||
* [[Eculizumab]] | |||
* [[Esomeprazole]] | * [[Esomeprazole]] | ||
* [[Exenatide]] | |||
* [[Live attenuated influenza vaccine|FluMist]] | * [[Live attenuated influenza vaccine|FluMist]] | ||
* [[Fulvestrant]] | * [[Fulvestrant]] | ||
* [[Gefitinib]] | * [[Gefitinib]] | ||
* [[Glycopyrronium bromide/formoterol]] | |||
* [[Goserelin]] | * [[Goserelin]] | ||
* [[Isosorbide mononitrate]] | * [[Isosorbide mononitrate]] | ||
* [[Metoprolol]] | |||
* [[Motavizumab]] | * [[Motavizumab]] | ||
* [[Olaparib]] | |||
* [[Omeprazole]] | * [[Omeprazole]] | ||
* [[Osimertinib]] | |||
* [[Palivizumab]] | * [[Palivizumab]] | ||
* [[Propofol]] | * [[Propofol]] | ||
* [[Quetiapine]] | |||
* [[Ravulizumab]] | |||
* [[Roflumilast]] | |||
* [[Rosuvastatin]] | * [[Rosuvastatin]] | ||
* [[Roxadustat]] | |||
* [[Salbutamol/budesonide]] | |||
* [[Savolitinib]] | |||
* [[Saxagliptin]] | |||
* [[Sebelipase alfa]] | |||
* [[Selumetinib]] | |||
* [[Sodium zirconium cyclosilicate]] | |||
* [[Tamoxifen]] | * [[Tamoxifen]] | ||
* [[Ticagrelor]] | * [[Ticagrelor]] | ||
* [[Tixagevimab/cilgavimab]] | |||
* [[Trastuzumab deruxtecan]] | |||
* [[Vandetanib]] | * [[Vandetanib]] | ||
* [[Oxford–AstraZeneca COVID-19 vaccine|Vaxzevria]] | |||
* [[Ximelagatran]] | * [[Ximelagatran]] | ||
* [[Zafirlukast]] | * [[Zafirlukast]] | ||
* [[Zolmitriptan]] | * [[Zolmitriptan]] | ||
| group2 = Predecessors and<br>acquired companies | | group2 = Predecessors and<br />acquired companies | ||
| list2 = | | list2 = | ||
* [[Astra AB]] | * [[Astra AB]] | ||
* [[Alexion Pharmaceuticals]] | |||
* [[Cambridge Antibody Technology]] | * [[Cambridge Antibody Technology]] | ||
* [[MedImmune]] | * [[MedImmune]] | ||
| Line 48: | Line 78: | ||
}}<noinclude> | }}<noinclude> | ||
{{collapsible option}} | {{collapsible option}} | ||
[[Category:Sweden company templates]] | |||
[[Category:United Kingdom company templates]] | [[Category:United Kingdom company templates]] | ||
[[Category:Pharmaceutical company templates]] | |||
</noinclude> | </noinclude> | ||
